Insulin Raw Material - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB506249528

Publication Date:

June 10, 2024

Pages:

125

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The global market for Insulin Raw Material was estimated to be worth US$ 1943 million in 2023 and is forecast to a readjusted size of US$ 2482.7 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Raw Material, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Raw Material by region & country, by Type, and by Application.
The Insulin Raw Material market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Raw Material.
麻豆原创 Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Segment by Type:
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Intermediate-acting
Long-acting
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin Raw Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin Raw Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin Raw Material in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Insulin Raw Material Product Introduction
1.2 Global Insulin Raw Material 麻豆原创 Size Forecast
1.2.1 Global Insulin Raw Material Sales Value (2019-2030)
1.2.2 Global Insulin Raw Material Sales Volume (2019-2030)
1.2.3 Global Insulin Raw Material Sales Price (2019-2030)
1.3 Insulin Raw Material 麻豆原创 Trends & Drivers
1.3.1 Insulin Raw Material Industry Trends
1.3.2 Insulin Raw Material 麻豆原创 Drivers & Opportunity
1.3.3 Insulin Raw Material 麻豆原创 Challenges
1.3.4 Insulin Raw Material 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Raw Material Players Revenue Ranking (2023)
2.2 Global Insulin Raw Material Revenue by Company (2019-2024)
2.3 Global Insulin Raw Material Players Sales Volume Ranking (2023)
2.4 Global Insulin Raw Material Sales Volume by Company Players (2019-2024)
2.5 Global Insulin Raw Material Average Price by Company (2019-2024)
2.6 Key Manufacturers Insulin Raw Material Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insulin Raw Material Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insulin Raw Material
2.9 Insulin Raw Material 麻豆原创 Competitive Analysis
2.9.1 Insulin Raw Material 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Raw Material Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Raw Material as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Regular Human Insulin
3.1.2 Insulin Analogue
3.2 Global Insulin Raw Material Sales Value by Type
3.2.1 Global Insulin Raw Material Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insulin Raw Material Sales Value, by Type (2019-2030)
3.2.3 Global Insulin Raw Material Sales Value, by Type (%) (2019-2030)
3.3 Global Insulin Raw Material Sales Volume by Type
3.3.1 Global Insulin Raw Material Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insulin Raw Material Sales Volume, by Type (2019-2030)
3.3.3 Global Insulin Raw Material Sales Volume, by Type (%) (2019-2030)
3.4 Global Insulin Raw Material Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fast-acting
4.1.2 Intermediate-acting
4.1.3 Long-acting
4.2 Global Insulin Raw Material Sales Value by Application
4.2.1 Global Insulin Raw Material Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Raw Material Sales Value, by Application (2019-2030)
4.2.3 Global Insulin Raw Material Sales Value, by Application (%) (2019-2030)
4.3 Global Insulin Raw Material Sales Volume by Application
4.3.1 Global Insulin Raw Material Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Raw Material Sales Volume, by Application (2019-2030)
4.3.3 Global Insulin Raw Material Sales Volume, by Application (%) (2019-2030)
4.4 Global Insulin Raw Material Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insulin Raw Material Sales Value by Region
5.1.1 Global Insulin Raw Material Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insulin Raw Material Sales Value by Region (2019-2024)
5.1.3 Global Insulin Raw Material Sales Value by Region (2025-2030)
5.1.4 Global Insulin Raw Material Sales Value by Region (%), (2019-2030)
5.2 Global Insulin Raw Material Sales Volume by Region
5.2.1 Global Insulin Raw Material Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insulin Raw Material Sales Volume by Region (2019-2024)
5.2.3 Global Insulin Raw Material Sales Volume by Region (2025-2030)
5.2.4 Global Insulin Raw Material Sales Volume by Region (%), (2019-2030)
5.3 Global Insulin Raw Material Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insulin Raw Material Sales Value, 2019-2030
5.4.2 North America Insulin Raw Material Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insulin Raw Material Sales Value, 2019-2030
5.5.2 Europe Insulin Raw Material Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Raw Material Sales Value, 2019-2030
5.6.2 Asia Pacific Insulin Raw Material Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insulin Raw Material Sales Value, 2019-2030
5.7.2 South America Insulin Raw Material Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Raw Material Sales Value, 2019-2030
5.8.2 Middle East & Africa Insulin Raw Material Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Raw Material Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insulin Raw Material Sales Value
6.2.1 Key Countries/Regions Insulin Raw Material Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insulin Raw Material Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insulin Raw Material Sales Value, 2019-2030
6.3.2 United States Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insulin Raw Material Sales Value, 2019-2030
6.4.2 Europe Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insulin Raw Material Sales Value, 2019-2030
6.5.2 China Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insulin Raw Material Sales Value, 2019-2030
6.6.2 Japan Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insulin Raw Material Sales Value, 2019-2030
6.7.2 South Korea Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Raw Material Sales Value, 2019-2030
6.8.2 Southeast Asia Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insulin Raw Material Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insulin Raw Material Sales Value, 2019-2030
6.9.2 India Insulin Raw Material Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insulin Raw Material Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Insulin Raw Material Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Company Information
7.2.2 Sanofi-Aventis Introduction and Business Overview
7.2.3 Sanofi-Aventis Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi-Aventis Insulin Raw Material Product Offerings
7.2.5 Sanofi-Aventis Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Information
7.3.2 Eli Lilly Introduction and Business Overview
7.3.3 Eli Lilly Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly Insulin Raw Material Product Offerings
7.3.5 Eli Lilly Recent Development
7.4 Tonghua Dongbao
7.4.1 Tonghua Dongbao Company Information
7.4.2 Tonghua Dongbao Introduction and Business Overview
7.4.3 Tonghua Dongbao Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Tonghua Dongbao Insulin Raw Material Product Offerings
7.4.5 Tonghua Dongbao Recent Development
7.5 Ganlee
7.5.1 Ganlee Company Information
7.5.2 Ganlee Introduction and Business Overview
7.5.3 Ganlee Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ganlee Insulin Raw Material Product Offerings
7.5.5 Ganlee Recent Development
7.6 United Laboratory
7.6.1 United Laboratory Company Information
7.6.2 United Laboratory Introduction and Business Overview
7.6.3 United Laboratory Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.6.4 United Laboratory Insulin Raw Material Product Offerings
7.6.5 United Laboratory Recent Development
7.7 Biocon
7.7.1 Biocon Company Information
7.7.2 Biocon Introduction and Business Overview
7.7.3 Biocon Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biocon Insulin Raw Material Product Offerings
7.7.5 Biocon Recent Development
7.8 Amphastar
7.8.1 Amphastar Company Information
7.8.2 Amphastar Introduction and Business Overview
7.8.3 Amphastar Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Amphastar Insulin Raw Material Product Offerings
7.8.5 Amphastar Recent Development
7.9 Wockhardt
7.9.1 Wockhardt Company Information
7.9.2 Wockhardt Introduction and Business Overview
7.9.3 Wockhardt Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Wockhardt Insulin Raw Material Product Offerings
7.9.5 Wockhardt Recent Development
7.10 Julphar Diabetes
7.10.1 Julphar Diabetes Company Information
7.10.2 Julphar Diabetes Introduction and Business Overview
7.10.3 Julphar Diabetes Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Julphar Diabetes Insulin Raw Material Product Offerings
7.10.5 Julphar Diabetes Recent Development
7.11 Torrent Pharma
7.11.1 Torrent Pharma Company Information
7.11.2 Torrent Pharma Introduction and Business Overview
7.11.3 Torrent Pharma Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Torrent Pharma Insulin Raw Material Product Offerings
7.11.5 Torrent Pharma Recent Development
8 Industry Chain Analysis
8.1 Insulin Raw Material Industrial Chain
8.2 Insulin Raw Material Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insulin Raw Material Sales Model
8.5.2 Sales Channel
8.5.3 Insulin Raw Material Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.